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Abstract 
Autism Spectrum Disorders (ASD) are a group of heterogeneous neurodevelopmental disorders with an 
estimated worldwide prevalence of 1-2%. Although it is highly heritable, the contribution of environmental 
factors and risk associated genes on the aberrant brain development is not well understood. In this review, we 
summarise some of the key risk factors and explore ASD associated cellular pathology from the perspective of 
the four predominant cells in the brain; neurons, oligodendrocytes, microglia and astrocytes. Further, we discuss 
the contributions of the associated cellular pathology to the three common hypotheses of ASD. We highlight the 
major neuro-pathologies underlying ASD, however more research is needed to ensure appropriate and efficient 
therapies can be directed towards ASD. 
 
Keywords: Autism spectrum disorders, Neurodevelopment, Neural lineage cells, Genetics, Risk factors. 
Citation: Savory, K., Syed, YA. Advances in the understanding of cellular pathogenesis associated with Autism 
Spectrum Disorder. 2020 Jan 22; 2(2):96-118. Journal for ReAttach Therapy and Developmental Diversities. 
https://doi.org/10.26407/2019jrtdd.1.21   
Copyright ©2019 Savory, K., Syed, YA. This is an open-access article distributed under the terms of the Creative 
Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0) 
 
 
 
 
 
 
 
 
 
 
 
 
Corresponding address: 
Yasir Ahmed Syed 
Neuroscience and Mental Health Research Institute,  
Hadyn Ellis Building, Cardiff, CF24 4HQ, UK 
Tel: +44(0)2920 688 314 
E-mail: syedy@cardiff.ac.uk 
  
Medical Aspects of Disability 
__________________________________________________________________________________  
Journal for ReAttach Therapy and Developmental Diversities 2020 Jan 22; 2(2):96-118                                  97 
 
1. Introduction 
Autism spectrum disorders (ASD) are a group of 
complex neurodevelopmental disorders 
characterised by deficits in social communication 
and interaction, restrictive and repetitive behaviours 
(American Psychiatric, 2013) and can also involve 
sensory abnormalities (Adamson, O'Hare, & 
Graham, 2006; Wiggins, Robins, Bakeman, & 
Adamson, 2009). Symptoms associated with ASD 
emerge during infancy and this disorder is most 
commonly diagnosed in early childhood. Due to 
better diagnosis, the prevalence of ASD has 
increased over the years (Baio et al., 2018; Idring et 
al., 2015), with recent reports suggesting that as 
many as 1 in 59 have ASD (Baio et al., 2018), with 
an estimated prevalence of 1 in 88 in the United 
Kingdom (Brugha et al., 2012). The ever-changing 
landscape associated with diagnosis and genetics of 
ASD has made it difficult to estimate the true 
prevalence in the population. ASD is more 
commonly diagnosed in males, with ratios 
suggesting around four times as much compared to 
females (Scott, Baron-Cohen, Bolton, & Brayne, 
2002). 
This article aims to briefly review the risk factors and 
genetics for autism spectrum disorders and will then 
go on to explore the contribution of neural lineage 
cells to the pathogenesis of this disorder. 
2. Risk Factors Associated with ASD 
It is now well established that ASD is caused by 
aberrant brain development, however the causal 
links are currently unknown. Although ASD is 
highly heritable, environmental factors also play a 
key role in the aetiology of these disorders. 
2.1 Prenatal risk factors 
Many risk factors have been associated with ASD 
both during the prenatal period and early infancy. 
Advanced maternal age of over 35 years has been 
commonly associated with an increased risk of the 
offspring developing ASD (D. Bilder, Pinborough-
Zimmerman, Miller, & McMahon, 2009; 
Pinborough-Zimmerman et al., 2011; K. Williams, 
Helmer, Duncan, Peat, & Mellis, 2008), with some 
suggesting being over 30 years could also be a risk 
(Idring et al., 2014). Additionally, advanced paternal 
age has also been associated with increased risk 
(Ben Itzchak, Lahat, & Zachor, 2011). Furthermore, 
males are diagnosed earlier if they have older 
parents (Darcy-Mahoney et al., 2016). 
Demographic factors also have been implicated 
with increased risk for ASD, where people of 
Caucasian ethnicity seem to be at increased risk 
(Pinborough-Zimmerman et al., 2011). 
Maternal obesity has been positively associated with 
an increased risk for ASD (Y.-M. Li et al., 2016). 
Low birth weight, defined as a newborn weighing 
less than 2500g (Blanc & Wardlaw, 2005) and 
prematurity (often associated with a low birth 
weight) have also been shown to contribute towards 
an increased risk of ASD (Ben Itzchak et al., 2011; 
Maramara, He, & Ming, 2014; K. Williams et al., 
2008). Additionally, increased weight gain during 
pregnancy (D. A. Bilder et al., 2013; Windham et 
al., 2019) and poor nutrition (Geetha, Sukumar, 
Dhivyadeepa, Reddy, & Balachandar, 2019) have 
been linked to childhood ASD. 
In addition to demographic and maternal factors, a 
range of obstetric complications have been 
associated with increased risk of ASD including 
fetal hypoxia (Burstyn, Wang, Yasui, Sithole, & 
Zwaigenbaum, 2011; Froehlich-Santino et al., 
2014), high maternal blood pressure (Polo-Kantola 
et al., 2014) and respiratory distress (Froehlich-
Santino et al., 2014). 
Emerging studies looking at maternal mental health 
and high functioning ASD phenotypes show a 
positive association. Poor mental health, particularly 
depression and anxiety which have become 
increasingly prevalent during pregnancy (Heron, 
O'Connor, Evans, Golding, & Glover, 2004; 
Janssen et al., 2018; Lockwood Estrin et al., 2019), 
have often been associated with adverse effects on 
the offspring both physically and cognitively (Glynn 
et al., 2018; Kataja et al., 2019; Y. Liu et al., 2012; 
O'Connor, Heron, Golding, Beveridge, & Glover, 
2002; Uguz et al., 2013). Both prenatal mental 
health (Hagberg, Robijn, & Jick, 2018) and the use 
of antidepressants, including the commonly 
prescribed selective serotonin reuptake inhibitors 
(SSRIs), during pregnancy have been associated 
with an increased risk of ASD (Gidaya et al., 2014; 
Hviid, Melbye, & Pasternak, 2013; Sujan et al., 
2017).. 
2.2 Environmental risk factors 
Exposure to neurotoxins, malnutrition associated 
with sociodemographics and medication taken in 
pregnancy during the critical period of development 
can have an accumulative effect on the risk of 
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developing this neurodevelopmental disorder. 
Studies have shown that exposure to a number of 
toxicants in the environment increase the risk of ASD 
during the prenatal period and after birth, including 
pesticides, air pollutants, diesel, nitrogen dioxide and 
living in an urban environment (Chang, Cole, & 
Costa, 2018; Flores-Pajot, Ofner, Do, Lavigne, & 
Villeneuve, 2016; Kalkbrenner, Schmidt, & 
Penlesky, 2014; Lauritsen et al., 2014). However, one 
large cohort study suggested that only exposure to a 
small percentage of neurotoxicants were associated 
with increased risk of ASD (Talbott et al., 2015). 
Increasing evidence has suggested that inflammation 
as a result of the physiological stress response due to 
maternal infection and immune activation is 
associated with an increased risk in the offspring 
developing ASD (Careaga, Murai, & Bauman, 
2017). Maternal infections (Atladóttir et al., 2010; 
Visser et al., 2013) and influenza (Zerbo et al., 2013) 
during pregnancy and autoimmune diseases (Vinet et 
al., 2015) have been associated with increased risk 
and earlier diagnosis of ASD. Evidence has 
suggested that maternal immune activation leads to 
localised loss of inhibitory neurons (Shin Yim et al., 
2017) and is associated with a certain profile of gut 
bacteria that promote inflammation (Caprioli, 
Pallone, & Monteleone, 2008; S. Kim et al., 2017). 
Gastrointestinal problems and altered gut microbiota 
in patients with ASD have also been reported 
(Finegold et al., 2002; F. Liu et al., 2019; Valicenti-
McDermott et al., 2006; B. L. Williams, Hornig, 
Parekh, & Lipkin, 2012), with one study showing a 
positive association between ASD severity and 
gastrointestinal symptoms (Adams, Johansen, 
Powell, Quig, & Rubin, 2011). 
In addition to the gut, nutrient deficiency has also been 
associated with ASD. Many studies have suggested a 
link between vitamin D deficiency prenatally and in 
children with autistic traits and ASD (Bener, Khattab, 
& Al-Dabbagh, 2014; Bener, Khattab, Bhugra, & 
Hoffmann, 2017; Vinkhuyzen et al., 2018). Maternal 
deficiency in many other nutrients including iron, 
zinc and vitamin B9 have also been associated with 
ASD (Nuttall, 2017). 
3. Genetics Associated with ASD 
The wide phenotypic variability of ASD along with 
twin studies suggest a strong association of genetics 
towards aetiology (Constantino et al., 2013; 
Ozonoff et al., 2011; Rosenberg et al., 2009). 
Whole exome sequencing (WES) has been a 
powerful tool to highlight genetic associations with 
Autism. One such study suggested that all de novo 
changes (including missense mutations and copy 
number variations; CNVs) account for as much as 
30% of ASD diagnoses (Iossifov et al., 2014). WES 
has discovered 11 de novo mutations in protein-
coding genes including FOXP1, GRIN2B, SCN1A 
and LAMC3 (O'Roak et al., 2011). A further large 
study utilising this method looked at data from 
almost 12,000 ASD cases and additional controls 
(Satterstrom et al., 2018). This study revealed 102 
risk genes for ASD, 31 of which were novel. Whole 
genome sequencing has also uncovered de novo 
mutations associated with ASD, revealing that the 
majority of these mutations were paternally 
inherited, however clustered de novo mutations 
(within 20kb) were mostly maternally inherited and 
in close proximity to CNVs (Yuen et al., 2016).  
Genome-wide association studies (GWAS) have 
been utilised to study large data sets to uncover de 
novo mutations, single nucleotide polymorphisms 
(SNPs) and CNVs associated with ASD. A recent 
large GWAS looking at data on 18,381 subjects 
with ASD and 27,969 controls highlighted five loci 
associated with increased risk of ASD in 
chromosomes 1, 7, 8 and 20 (Xia et al., 2013). 
Specifically, the genes linked to these loci included 
PTBP2 (1p21.3), SRPK2 (7q22.3), SOX7, PINX1 
(8p23.1), and NKX2-2, NKX2-4 (20p11.23), 
MACROD2 (20p12.1) (Grove et al., 2019), a 
number of which have been implicated in 
neurodevelopment. Additionally, SNPs in 1p13.2 
including the TRIM33 gene showed links with 
autism. Additionally, three genes essential for 
neuronal function; CACNA1C, MECP2 and PTEN 
have also been associated with increased risk of 
Autism (Busch et al., 2019; J. Li et al., 2015; Wen et 
al., 2017). 
A number of other GWAS studies have highlighted 
CNVs associated with an increased risk of autism. 
CNVs were found in over a quarter of patients with 
ASD in a Greek population, with the majority being 
deletions (Oikonomakis et al., 2016). Rare CNVs 
are higher in patients with ASD compared to 
controls (Pinto et al., 2010) with a gene enrichment 
analysis showing implicated genes were associated 
with neuronal development and function. Another 
study showed duplications at 1q21.1 and 15q11-13 
and deletions at 16p11.2 and 22q11.21 were 
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associated with risk for ASD (Crespi & Crofts, 
2012). 
One study suggested a large number of SNPs in 
5p14.1 to be associated with an increased risk of 
autism, however these did not reach genome-wide 
significance (Ma et al., 2009). A further study 
looking at this same region found strong 
associations in SNPs between the cadherin genes; 
CDH9 and CDH10 (K. Wang et al., 2009). A 
GWAS meta-analysis of patients with ASD and 
controls found a number of SNPs in genes at 
10q24.32 showed genome-wide significance 
(Autism Spectrum Disorders Working Group of 
The Psychiatric Genomics, 2017). Genes in this 
implicated region are associated with a number of 
neurodevelopmental processes. Further, a small 
deletion consisting of five genes (MVP, CDIPT1, 
SEZ6L2, ASPHD1 and KCTD13) in the 16p11.2 
region were found to be associated with ASD 
suggesting a minimal deletion region for ASD risk 
(Crepel et al., 2011). 
A table of specific gene functions is provided for 
genes discussed in this section (table 1). 
 
Table 1 
Physiological function of genes associated with increased risk of ASD 
 
Gene Specific gene function Chromosomal 
location 
Neurogenesis 
PTBP2 Crucial for axon development through alternative splicing (M. Zhang 
et al., 2019) and maturation of neurons (Q. Li et al., 2014). 
1p21.3 
EFA6 Involved in axonal transport and regeneration (Eva, Koseki, 
Kanamarlapudi, & Fawcett, 2017) and neuronal morphogenesis, 
particularly the development of dendrites (Sakagami et al., 2007; 
Sakagami, Matsuya, Nishimura, Suzuki, & Kondo, 2004; Sironi et al., 
2009). 
10q24.32 
PITX3 Required for optimal development of Mesodiencephalic dopamine 
neurons (Kouwenhoven, von Oerthel, & Smidt, 2017; Le, Zhang, Xie, 
Li, & Dani, 2015). 
10q24.32 
KCTD13 Associated with the development of cortical neurons (Gladwyn-Ng et 
al., 2016) and synaptic transmission (Escamilla et al., 2017). 
16p11.2 
SEZ6L2 Seizure 6-like protein. Essential for the development of dendrites and 
neurites (Boonen et al., 2016; Yaguchi et al., 2017) and connectivity of 
synapses (Gunnersen et al., 2007). 
16p11.2 
MACROD2 Expressed in hippocampal neurons during development and may be 
involved in neurogenesis (Ito et al., 2018), although a physiological role 
has yet to be identified. 
20p12.1 
NKX2-2 Implicated in the development of dopamine neurons (Prakash et al., 
2006), motor neurons (Clark et al., 2014; Jarrar, Dias, Ericson, Arnold, 
& Holz, 2015), interneurons and oligodendrocytes (Jarrar, Vauti, 
Arnold, & Holz, 2015; Zhu et al., 2014). 
20p11.22 
NKX2-4 Involved in neurogenesis of cortical (Shen et al., 2017) and 
hypothalamic (Manoli & Driever, 2014) neurons. 
20p11.23 
Synaptogenesis 
CHD9 Regulates synapses in the hippocampus (M. E. Williams et al., 2011) 
and has been implicated in chromatin organisation (Ooga et al., 2018). 
5p14.1 
CHD10 Involved in the regulation of E/I synapses (Smith et al., 2017). 5p14.1 
SHANK2 Essential for synapse development and plasticity (Ha et al., 2016; 
Wegener et al., 2018). 
11q13.3-q13.4 
Inflammation 
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CUEDC2 Implicated in inflammation (Man & Zhang, 2011). 10q24.32 
NFκB2 Associated with a variety of immune responses (Cubillos-Zapata et al., 
2014; Doyle et al., 2013) and inflammation (Yang et al., 2018). 
10q24.32 
MVP Supresses inflammation through NF-κB signalling (Ben et al., 2019; 
Peng et al., 2016). 
16p11.2 
Cell death 
SPRK2 Regulates neuronal apoptosis through Akt phosphorylation (Jang et al., 
2009). 
7q22.3 
SOX7 Implicated in inhibition of the Wnt pathway (Fan et al., 2018; C. Wang 
et al., 2015). 
8p23.1 
Other   
CDIPT1 Associated with endoplasmic reticulum stress (Thakur et al., 2011). 16p11.2 
 
3.1. Neurexins and Neuroligins 
The CNV syndrome 22q13.3 region associated 
with high incidences of ASD-like behaviour 
includes the SHANK3 gene encoding a synaptic 
scaffolding protein (Durand et al., 2007; Phelan & 
McDermid, 2012). SHANK3 binds to neuroligins 
(Meyer, Varoqueaux, Neeb, Oschlies, & Brose, 
2004), which interact with neurexins to form 
glutamatergic synapses (Craig & Kang, 2007). A 
GWAS of the visual sensitivity phenotype 
associated with ASD showed a SNP in PDZK1, 
located at 1q21.1, was associated with increased 
sensitivity (Goodbourn et al., 2014). Further, PDZ 
domains have been shown to bind to the neuroligin 
NLGN1 (Meyer et al., 2004). Both neurexins and 
neuroligins have been associated with ASD. NLG1 
and NLG4, but not NLG3 and NLG4Y have been 
associated with autism (Ylisaukko-oja et al., 2005) 
with a drosophila model of deficient Nlg2 and Nlg4 
showing abnormalities in social behaviour (Corthals 
et al., 2017). SNPs in NRXN2 and NRXN3 have 
been associated with increased risk of ASD (J. 
Wang et al., 2018), additionally missense mutations 
in NRXN1 were found in two patients with ASD 
(Kim et al., 2008). 
4. Contribution of Neural Lineage Cells 
in the Pathogenesis of ASD 
4.1 Neurons 
ASD is a disorder caused by aberrant 
neurodevelopment. The predominant cells in the 
brain, and thus most likely to be affected by adverse 
neurodevelopment, are neurons and glial cells. 
Neuronal research appears to be the main area of 
study in relation to ASD and a number of neuronal 
cells have been implicated in function, morphology, 
axon guidance and synaptic dysregulation, 
including immature neurons, pyramidal neurons 
located in the prefrontal cortex (PFC), mature 
cortical neurons, inhibitory neurons including 
GABAergic neurons and excitatory neurons. 
Macrocephaly has been associated in a number of 
cases of autism (Courchesne, Carper, & 
Akshoomoff, 2003; McBride et al., 2010) and larger 
brain volume in patients with autism has also been 
reported (Aylward, Minshew, Field, Sparks, & 
Singh, 2002). The cause of macrocephaly is 
unknown, however it may be associated with the 
number, maturity and morphology of neurons. One 
study found that children with autism had 
significantly more neurons in the PFC which 
correlated with increased brain weight (Courchesne 
et al., 2011). The phosphatase and tensin homolog 
(PTEN) gene is clearly associated with 
macrocephaly in ASD (Goffin, Hoefsloot, 
Bosgoed, Swillen, & Fryns, 2001) with a brain 
organoid model harbouring a deletion of this gene 
showing an increase in proliferation of cells leading 
to large sized organoids (Y. Li et al., 2017). 
Conversely, it has been found that larger spine 
densities of pyramidal neurons are associated with a 
smaller brain size (Hutsler & Zhang, 2010). Whilst 
macrocephaly is more prominently reported in 
ASD, microcephaly can also occur in some cases 
(Fombonne, Rogé, Claverie, Courty, & Kruck, 
1999). 
Altered morphology of neurons has been reported in 
many ASD cases which may be related to the 
symptoms of autism. One study showed patients 
with autism have smaller pyramidal neurons in the 
PFC (Jacot-Descombes et al., 2012), an area 
implicated in social behaviour (Anderson, Bechara, 
Damasio, Tranel, & Damasio, 1999). Further, 
Medical Aspects of Disability 
__________________________________________________________________________________  
Journal for ReAttach Therapy and Developmental Diversities 2020 Jan 22; 2(2):96-118                                  101 
 
altered morphology of neurons from human cases 
and animal models of ASD have been found in the 
amygdala (Jerzy Wegiel et al., 2015) and 
hippocampus (Griesi-Oliveira et al., 2015); areas 
both associated with the anxiety and emotional-
related memory features of autism (Babaev, Piletti 
Chatain, & Krueger-Burg, 2018; Boucher, Mayes, 
& Bigham, 2012; Bowler, Gaigg, & Gardiner, 
2014). A less-reported symptom of ASD is deficits 
in face processing (Davies, Bishop, Manstead, & 
Tantam, 1994; Grelotti, Gauthier, & Schultz, 2002; 
Joseph & Tanaka, 2003). One study found that 
neurons in the fusiform gyrus, an essential area for 
face processing (Kanwisher, McDermott, & Chun, 
1997), were significantly less dense and reduced in 
number in brains from patients with autism (van 
Kooten et al., 2008). Further, overexpression of 
SHANK2 in neurons; a gene associated with autism 
when defective, was associated with shorter and less 
neurites (Luo et al., 2019). 
Mouse models are a useful tool for understanding 
the mechanisms by which neuronal morphology is 
altered in ASD and many studies have successfully 
recapitulated the key symptoms of autism including 
impaired social behaviour and repetitive behaviour. 
One mouse model exhibiting impaired social 
behaviour showed that the reduced spine pruning in 
pyramidal neurons found in post-mortem brains of 
ASD patients was likely to be caused by impaired 
autophagy as a result of defects in the m-TOR 
pathway (Tang et al., 2014). 
It is not only altered morphology of neurons that has 
been implicated in ASD, but also deficits in 
migration and proliferation. Brains from patients 
with autism show defects in neurogenesis and 
migration of neurons (Jerzy Wegiel et al., 2010). 
Mouse models with Shank3 knockout (KO) 
mutations, which have been associated with autism 
(Boccuto et al., 2013; Durand et al., 2007; Gauthier 
et al., 2009), showed decreased radial glial 
progenitor cells and immature neurons in the 
hippocampus (Cope et al., 2016). A number of 
mouse models have shown that an increase in early 
neurogenesis is associated with deficits in early 
maturity (Orosco et al., 2014) and morphology 
(Arranz et al., 2019). Further, an increase in 
proliferation of progenitor cells has been associated 
with decreased mature pyramidal neurons in a 
mouse model of CNV syndrome 16p11.2 deletion, 
harbouring the MAPK3 gene (Pucilowska et al., 
2015). Deficits in proliferation of cortical neurons 
have been shown in animal models of ASD, 
including a study looking at a knockdown of the 
autism-associated gene Chd8 in primary cortical 
neurons (Xu et al., 2018). A well-established rat 
model found that reduced proliferation was due to 
overexpression of a gene targeting Fzd3 and 
inhibiting the Wnt pathway (Yao, Huang, & He, 
2019), inhibition of this pathway has also been 
associated with increased proliferation of neural 
progenitor cells through reduced transcriptional 
activity of β-catenin (Marchetto et al., 2017). 
The identification of synaptic proteins controlling 
synapse formation and signalling implicated in 
ASD points towards synaptic malformation and 
dysfunction (De Rubeis et al., 2014). For example, 
mutations in synaptic neuroligin genes NLGN3 and 
NLGN4 have been associated with ASD (Jamain et 
al., 2003; Südhof, 2008). Mice with these deletions 
have been shown with synaptic defects (Gutierrez et 
al., 2009; C. Zhang et al., 2009). Mutations in 
synapsins (SYN1, SYN2, SYN3); a family of 
presynaptic proteins that regulate vesicle-mediated 
neurotransmitter release and neurites, have been 
found in individuals with autistic phenotypes, 
suggesting a potentially causative factor of ASD 
(Fassio et al., 2011). Primary neurons from Syn1/2/3 
triple-KO mice display a significant decrease in the 
number of synaptic vesicles (Fornasiero et al., 2012) 
and display impairments in social recognition tests 
and a decreased environmental interest; phenotypic 
of ASD (Greco et al., 2013; Ketzef & Gitler, 2012). 
The SHANK3 gene strongly associated with ASD 
seems to confer its pathology through synaptic 
dysfunction. Neurons lacking in SHANK3 are 
associated with fewer synapses, whereas 
overexpression of SHANK3 results in more mature 
neurons with larger spines (Betancur, Sakurai, & 
Buxbaum, 2009). Furthermore, single-gene 
mutations associated with ASD such as fragile X 
syndrome (FMR1), tuberous sclerosis (TSC1, 
TSC2), neurofibromatosis type-1 (NF1), Angelman 
syndrome (UBE3A), Rett syndrome (MECP2), and 
the PTEN hamartoma tumour syndrome seem to 
mediate their effect through synaptic dysregulation 
(Zoghbi & Bear, 2012). A recent study looking at 
the effect of the KO of Rnf8, linked to ASD, 
demonstrates a 50% increase in the number of 
synapses in cerebellar neurons (Valnegri et al., 
2017). Taken together, it can be argued that synaptic 
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dysfunction plays a major role in the pathogenesis of 
ASD. 
The excitatory-inhibitory (E/I) balance theory of 
autism has become increasingly of interest in recent 
years in an attempt to explain the wide range of 
symptoms and common pathologies associated 
with ASD including repatative behaviours, 
hyperactivity, anxiety and epilepsy (Rubenstein & 
Merzenich, 2003). Evidence from human patients 
has shown increased formation of excitatory 
synapses associated with increased IL-6 in the 
cerebellum of patients (Hongen Wei et al., 2011). A 
mixture of results have been found from studies 
using human induced pluripotent stem cells 
(hiPCSs) derived from ASD patients. Glutamate is 
the most abundant excitatory neurotransmtter in the 
brain (Fonnum, 1984) and decreased levels have 
been shown along with a reduction in synapses of 
neural progenitor cells (Marchetto et al., 2017) and 
mature neurons (Russo et al., 2018). Further, an 
increase in GABAergic neurons; responsible for the 
secretion of the main inhibitory neurotransmitter in 
the brain, has been found in neural progenitor cells 
(Marchetto et al., 2017) and telencephalic organoids 
(Mariani et al., 2015). 
The well-established Shank3 KO model has shown 
impaired morphology of inhibitory neurons with 
longer dendrites, but decreased spine and 
postsynaptic density (Peça et al., 2011) and down-
regulation of a sub-type of inhibitory neuron (Filice, 
Vörckel, Sungur, Wöhr, & Schwaller, 2016), 
however another study showed that activity in both 
inhibitory and excitatory neurons was reduced 
(Huang et al., 2019). Further, mouse models have 
shown a decrease in a type of positive inhibitory 
interneuron (Pucilowska et al., 2015) and 
overproduction of excitatory neurons (Fang et al., 
2014) in upper layers of the cortex. 
The discrepancy between these findings could be 
explained by the different types of inhibitory and 
excitatory neurons in the brain. The Mef2c mouse 
model of autism that displays ASD-like symptoms 
including impaired social interaction showed a 
decrease in excitatory transmission and increase in 
inhibitory transmission in cortical neurons 
(Harrington et al., 2016). Further, a mouse model of 
autism involving the Ib2 KO, associated with 
deficits in motor and cognitive function (Giza et al., 
2010), showed increased excitability through 
enhanced neurotransmission from NMDA 
receptors (Soda et al., 2019). Another potential 
explanation is that the number of neurons do not 
always directly relate to the amount of inhbitory or 
excitatory nerotransmiter release, for example, a 
heterozygous KO of Dyrk1a shows ASD like-
behaviours and increased number of both excitatory 
and inhibitory neurons, but only a significant 
increase in excitatory synapses (Arranz et al., 2019). 
Overall, these findings suggest a predominancy 
excitatory E/I balance could be a factor in the clinical 
phenotypes associated with ASD. 
4.2. Oligodendrocytes 
Oligodendrocytes are the only myelin-forming cells 
of the mamilian central nervous system. In humans, 
half of the brain is composed of white matter, which 
is predominantly made of myelin, and is 500% 
more abundant in comparison to mice (K. Zhang & 
Sejnowski, 2000). Oligodendrocyte pathology has 
been found in patients with ASD. Adults with ASD 
show significantly lower numbers of 
oligodendrocytes (Morgan, Barger, Amaral, & 
Schumann, 2014). Further, pathology has been 
found in the PFC; an area associated with social 
behaviour (Finlay et al., 2015; Franklin et al., 2017; 
Pirone et al., 2018) and increased expression of 
oligodendrocyte markers have been found in the 
hippocampus and PFC, but are significnatly 
decreased in density in part of the hippocampus 
(Vargas, Nascimbene, Krishnan, Zimmerman, & 
Pardo, 2005). Brains from adult autistic patients 
have a lower amount of myelinated thin axons but 
an increase of medium thickness axons in the lateral 
PFC (Trutzer, García-Cabezas, & Zikopoulos, 
2019) and increased myelination in the medial PFC 
(Carmody & Lewis, 2010). This evidence could 
explain some of the social abnormalities seen in 
ASD. 
A number of genes and SNPs implicated in autism 
have been associated with oligodendrocytes. SNPs 
in the the DUSP15 and CD38 genes; involved in 
oligodendrocyte differentiation and development, 
have been found in children with autism (van 
Tilborg et al., 2018; Munesue et al., 2010; Hattori et 
al., 2017) and clearance of degraded myelin is also 
associalted with CD38 (Roboon et al., 2019). 
Chromatin remodelers including CHD7 and CHD8 
have been linked to ASD (Jiang et al., 2013; Xu et 
al., 2018). Loss-of-function Chd7 is associated with 
reduced number of oligodendrocyte progenitor cells 
(OPCs) through apoptosis (Marie et al., 2018). 
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Further, this gene has downstream effects on many 
genes involved in cell surival, proliferation and 
apoptosis [54]. Gene expression studies have also 
shown increased expression of genes associated 
with oligodendrocytes in the cerebellum from 
patients with autism including MBP, MAG, OLIG1, 
OLIG2 (Zeidán-Chuliá et al., 2016). Although 
contrasting results have been found in the BTBR 
mouse model of autism (H. Wei et al., 2016). 
Prenatal hypoxia and inflammation are risks factors 
for ASD. One mouse model using both hypoxia and 
inflammation to cause diffuse white matter injury 
showed autism-like behaviour in the mice. Further, 
they showed impaired maturation of 
oligodendrocytes and delayed myelination (van 
Tilborg et al., 2018). This study supports the notion 
that presence of inflammation contributes towards 
abberant myelination during neurodevelopment. 
Abnormal myelination has further been confirmed 
in two other mouse models of ASD showing both 
deficits in deposition and thickness of the myelin 
sheath (Graciarena, Seiffe, Nait-Oumesmar, & 
Depino, 2019; H. Lee, Thacker, Sarn, Dutta, & Eng, 
2019), with the latter showing decreased 
myelination in areas associated with social 
behaviour, potentially a result of imapired 
maturation of OPCs. On the contrary, another study 
looking into the effect of developmental 
myelination in a mouse model of Timothy 
syndrome, in which a gain-of-function mutation in 
the α1 subunit of the L-type calcium channel Cav1.2 
gives rise to an ASD phenotype, was associated 
with an increase in the number of mature 
oligodendrocytes and myelination (Cheli et al., 
2018). A recent study looking into the effect of 
Cyfip1; a critical gene in 15q11.2 deletion 
syndrome, demonstrate that deletion of this gene 
resulted in a decrease in the myelination in the 
corpus callosum and interfered with the learning 
abilit of rats (Silva et al., 2019). Taken together, 
dysregulation in oligodendrocyte differentiation and 
developmental myelination play an important role 
towards the pathogenic mechanisms of ASD. 
4.3. Microglia 
Microglia are the immune cells of the brain and are 
capable of producing and reacting to a range of 
immune responses by secreting cytokines (Hanisch, 
2002). Brains from autistic patients show increased 
size, density, number and activity of microglia in the 
PFC (Morgan et al., 2010; Tetreault et al., 2012). 
Animal models focusing on neurodevelopment 
have shown abnormal microglial morphology and 
decreased density in the PFC (Sanagi et al., 2019). 
Additionally, a mouse model of 15q11-q13 
duplication showed decreased amount of a 
microglia marker in the amygdala in early postnatal 
mice (Shigemori, Sakai, Takumi, Itoh, & Suzuki, 
2015). TREM2, an immune receptor known to 
regulate the level of neurons by activation of 
microglia, has been shown to be downregulated in 
the autistic brain (Filipello et al., 2018). The study 
demonstrated that Trem2 KO mice display altered 
sociability and was associated with repetitive 
behaviour. It is plausible that either deficient or too 
many microglia along with abnormal morphology 
cause some of the social and anxiety features of 
ASD. 
Microglia activation is another event associated with 
ASD. Active microglia is commonly seen as a sign 
of inflammation in the central nervous system 
(Dheen & Charanjit Kaur and Eng-Ang, 2007). 
Brains from autistic patients show increased 
activation of microglia along with pro inflammatory 
markers in both brain and cerebrospinal fluid (Patel, 
Tsilioni, Leeman, & Theoharides, 2016; Suzuki et 
al., 2013; Vargas et al., 2005). Increased neurotensin 
has been found in some children with autism and 
this peptide was shown to activate microglia 
through stimulation of the m-TOR pathway (Patel 
et al., 2016). Further, rodents injected with a drug 
that increased microglial activation showed ASD-
like behaviour (Zerrate et al., 2007). The glutamate 
receptor mGluR5; shown to decrease microglial 
activation (Loane, Stoica, Pajoohesh-Ganji, Byrnes, 
& Faden, 2009), has been shown to be significantly 
decreased in the brains of patients with autism 
accompanied by increase in pro-inflammatory 
markers (Chana et al., 2015). Research has shown 
that inflammation has an adverse effect on 
neurodevelopment (van der Burg et al., 2015). 
Together, these studies suggest that, at least in part, 
there is an inflammatory pathology in ASD. 
Microglia may also have a role in the physical 
development of neurons. Evidence from brains of 
patients with autism have shown microglia exist in a 
much closer proximity to neurons in patients 
(Morgan et al., 2012). Whilst the phenotypical result 
of this interaction is unknown, research in other 
areas have shown microglia become close in 
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proximity to neurons when motor neurons are 
degenerating in a model of motor neuron disease 
(Toedebusch et al., 2018). Other studies have shown 
prolonged microglial-neuronal contact after 
damage, in particular with the synapses (Wake, 
Moorhouse, Jinno, Kohsaka, & Nabekura, 2009). 
This may be an attempt of synaptic pruning; an 
essential mechanism of neurodevelopment 
(Paolicelli et al., 2011), to counterbalance the 
increased neurogenesis seen in autism. On the other 
hand, it may suggest defective microglia activation 
in ASD. It has been shown that the communication 
between neurons and microglia and deficits in 
synaptic pruning results in impaired social 
behaviour and repetitive behaviours (Zhan et al., 
2014); key features of autism. Another animal 
model of autism (Atg7 deficient) shows an increase 
in the number and density of dendritic spines and 
increased immature synapses as a result of deficits in 
synaptic pruning by microglia (H. J. Kim et al., 
2017). Research has also shown that brains of 
patients with autism have significantly higher 
expression of markers of microglia but neuronal 
markers are significantly decreased in the PFC 
(Edmonson, Ziats, & Rennert, 2014). This could 
suggest i) microglia are attempting to play a 
therapeutic role for defective neurons, ii) microglia 
themselves are defective and are causing neuronal 
harm, potentially through dysfunctional synaptic 
pruning. Furthermore, maternal immune activation; 
one of the risk factors for ASD, may potentially 
mediate its effect through microglial activation, 
which opens up an opportunity for 
immunomodulatory treatment options to rescue 
some of the associated phenotypes of ASD. 
4.4. Astrocytes 
Astrocytes are an integral part of the tripartite synapse 
(Eroglu & Barres, 2010) and play a key role in the 
regulatory control of synaptic function and plasticity, 
(Tewari & Parpura, 2016) which in turn play a key 
role in social behaviour and cognitive functions. 
Astrocytes have been less implicated in ASD 
compared to the three other major types of brain cells 
reviewed here (neurons, oligodendrocytes and 
microglia). This may be due to a reduced 
involvement in these disorders or a lack of research 
into the link between astrocytes and ASD. 
Research has shown contrasting results in regards to 
astrocytes and ASD. In the cerebellum, one study 
reported increased GFAP (Laurence & Fatemi, 
2005); a major marker of astrocytes, whereas another 
study showed a decrease of the astrocytic marker 
AQP4 (Fatemi, Folsom, Reutiman, & Lee, 2008) in 
brains of patients with autism. One explanation for 
these findings is the timing at which astrocytes may 
be more active during development. Earlier in 
development GFAP has been shown to be 
significantly increased, whilst expression decreased 
postnatally in the cerebellum (Vargas et al., 2005). 
This study further showed that whilst expression was 
decreased, there was an increase in protein, 
suggestive of post transcriptional modifications. 
Brains of patients with autism have shown an 
increase in FMRP in astrocytes, a protein essential for 
normal cognitive function (Santos, Kanellopoulos, & 
Bagni, 2014), but a decrease in neurons combined 
with neuronal deficits in the cerebral cortex (Jarek 
Wegiel et al., 2018). This may suggest that astrocytes 
are less affected by ASD and may not represent an 
area where pathology is evident. In support of this, 
typical astrocyte morphology was seen in the 
dorsolateral PFC from patients with autism (T. T. Lee 
et al., 2017) and a mouse model inducible KO of 
Glt1; the glutamate transporter secreted by astrocytes, 
did not show deficits in social behaviour (Aida et al., 
2015). On the other hand, one study showed Fmr1 
astrocyte KO mice had reduced expression of the 
excitatory protein Glt1 in astrocytes and impaired 
glutamate uptake, leading to increased extracellular 
glutamate and was associated with increased activity 
of pyramidal neurons (Higashimori et al., 2016). 
iPSC astrocytes from Rett syndrome patients seem to 
have accelerated differentiation (Andoh-Noda et al., 
2015). When wild-type neurons were cultured in 
conditioned media obtained from these astrocytes it 
led to an alteration in neural connectivity (E. C. 
Williams et al., 2014). Altogether, this research 
suggests that defective astrocytes contribute towards 
impaired neuronal health and the pathology of ASD. 
A summary of ASD risk factors and the 
contribution of neural lineage cells towards the 
pathology of ASD is given in figure 1. 
 
 
 
 
 
 
__________________________________________________________________________________
105                                                                                                                                                 https://jrtdd.com 
 
Figure 1: Contribution of the risk factors to the cellular pathologies and hypotheses associated with 
ASD.  
Diagram of risk factors, hypotheses of ASD and which neural lineage cells may be linked to these hypotheses. The solid 
arrows denote hypotheses with strong links to the relevant neural lineage cells. The dotted arrow shows a potential link 
between the hypothesis and neural lineage cells. 
4.5. Brain organoids 
Organoids are becoming increasingly popular ways 
to study structure and function of neural cells. There 
are a number of advantages of using 3D cellular 
model organoids over the widely-used 2D neural 
cultures. Organoids are much better models as they 
are able to replicate the development of the 
neocortex (Camp et al., 2015) and are improved 
models to test drugs for treatment due to their more 
complex structure and organisation (Ranga, 
Gjorevski, & Lutolf, 2014); better to recapitulate 
brain pathology over 2D models. Currently, due to 
the relative novelty of this cellular model, very little 
research on cerebral organoids and ASD have been 
conducted. Of the research published it has been 
shown that heterozygous knockouts of the CHD8 
gene replicate results of 2D cell culture in regards to 
differentially expressed genes associated with 
CHD8 and autism (P. Wang et al., 2015; P. Wang 
et al., 2017). One other study looking at 
overproduction of FOXG1 in patient-derived 
organoids showed an overproduction of 
GABAergic inhibitory neurons (Mariani et al., 
2015). Whilst this gene is not directly linked to 
autism, it has been associated with Rett Syndrome 
(Ariani et al., 2008); which involves a number of 
autistic-like features. Further, brain organoids are 
potential models to recapitulate morphological 
phenotypes of ASD, as discussed, the PTEN 
mutation leads to large sized organoids (Y. Li et al., 
2017); consistent with the macrocephaly phenotype 
of this gene mutation. 
5. Clinical Implications and Future 
Perspectives 
To make a difference in the lives of subjects with 
ASD, it is essential to provide a better diagnosis and 
an effective treatment. The therapies that are 
available for ASD varies widely for very young 
children and toddlers. While social and adaptive 
therapies have been recommended for young 
children, behavioural therapies have proven to be 
effective for adults. Due to the complex genetics 
associated with ASD, it is crucial to define and 
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investigate the impact of genetics on brain 
development and cellular pathogenesis such as 
impaired neural maturation and neuroinflammation. 
This information will serve as a basis for the 
development of effective therapies that can alleviate 
some of the symptoms. Furthermore, developing 
and refining the human cellular models that can 
identify a clear neurobiological process is crucial, as 
to develop a platform for the screening of drugs. 
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